Skip to main content
Tech.euFundingExplorerBeta

Dawn Biopharma

Investor profile

Corporate

Dawn Biopharma has backed 1 European tech company across 1 funding round in 2024, joining rounds totalling €80M. Most active in Healthtech. Data as of 4 Nov 2026.

Deals
1
distinct rounds
Companies
1
backed
Active span
2024
1 yr
Total round €
€80M
sum of rounds joined

Deals by year

distinct rounds / year
Dawn Biopharma — deals by year — interactive chart.
Data table
Dawn Biopharma — deals by year
20241

Top sectors

by deals
Dawn Biopharma — top sectors — interactive chart.
Data table
Dawn Biopharma — top sectors
Healthtech1

Stages

by deals
Dawn Biopharma — stages — interactive chart.
Data table
Dawn Biopharma — stages
Series A1

Countries

by deals
Dawn Biopharma — countries — interactive chart.
Data table
Dawn Biopharma — countries
Denmark1

Co-investment network

shared rounds
Co-investment network — interactive chart.
Dawn Biopharma — 1 dealsDawn BiopharmaExport and Investment Fund of Denmark (EIFO) — 1 shared deals · click to openExport and Investment Fund of Denmark (EIFO)Longview Ventures — 1 shared deals · click to openLongview VenturesNovo Holdings — 1 shared deals · click to openNovo HoldingsPictet — 1 shared deals · click to openPictetSR One — 1 shared deals · click to openSR OneVersant Ventures — 1 shared deals · click to openVersant Ventures

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Frequent co-investors

shared rounds

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
Antag TherapeuticsDenmark1€80M

Biggest deals

top 10 by amount
CompanyStageAmountDate
Antag TherapeuticsSeries A€80M2024-12
← Back to investors